HOME >> BIOLOGY >> NEWS
Einstein's Dr. E. Richard Stanley receives 2006 E. Donnall Thomas Prize

August 4, 2006 -- (Bronx, NY) -- E. Richard Stanley, Ph.D., professor and chair of developmental and molecular biology at Albert Einstein College of Medicine of Yeshiva University has been selected to receive the 2006 E. Donnall Thomas Prize, presented annually by the American Society of Hematology.

The Prize, which was established in 1992, recognizes a researcher whose ground-breaking work has contributed greatly to the field of hematology. In conjunction with receiving the honor, Dr. Stanley will present the E. Donnall Thomas Lecture at the Society's annual meeting in December in Orlando, Florida.

For more than a quarter-century, Dr. Stanley has pioneered studies of the biology and action of the growth factor called Colony Stimulating Factor-1 (CSF-1). He isolated and identified CSF-1 as the primary regulator of tissue macrophage and osteoclast production. He defined its receptor, physiology and roles in development and cancer. He identified and elucidated the function of several intracellular signaling molecules that act downstream of the CSF-1 receptor. He and his colleagues established several mouse models to investigate the roles of CSF-1 and the CSF-1 receptor in development and diseases that include leukemia, solid tumors, osteoporosis, nephritis and atherosclerosis. His studies also have furthered general understanding of the role of growth factors in regulation of cell proliferation, differentiation and function.

The Thomas Prize is one of numerous honors that Dr. Stanley has received throughout his career. Other notable honors include two Method to Extend Research in Time (MERIT) Awards from the National Institutes of Health, awarded in 1989 and 2002, respectively; a Leukemia Society of America Scholar Award (1977); an Irma T. Hirschl Career Scientist Award (1983); the Marie T. Bonazinga Research Award of the Society for Leukocyte Biology (1989); and being named to the "Roll of Honor" by the International Union Agains
'"/>

Contact: Karen Gardner
kgardner@aecom.yu.edu
718-430-3101
Albert Einstein College of Medicine
4-Aug-2006


Page: 1 2

Related biology news :

1. Einsteins Dr. Vern Schramm elected to the National Academy of Sciences
2. Einsteins Susan Band Horwitz, PhD wins Bristol-Myers Squibb Cancer Research Award
3. Richard Lifton awarded at WCN 2007
4. AACRs Sixth Annual Landon Awards recognize Richard Kolodner, Douglas Lowy and John Schiller
5. Richard Zare named Howard Hughes Medical Institute Professor
6. Richard Zare awarded the 2005 Wolf Prize in chemistry
7. HHMI researchers Richard Axel and Linda Buck win 2004 Nobel Prize
8. Carnegie Mellons Peter Adams receives EPA research grant
9. Philadelphia ecologist receives top Mongolia honor
10. VIB scientist receives major research grant
11. Maynard Olson receives $500,000 Gruber Genetics Prize

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... PENSACOLA, Fla. (PRWEB) , ... August 05, 2020 , ... ... to cover two new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly ... a defect using a syringe. The company’s solutions are the first Wharton’s jelly allograft ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has ... Invictus Medical Neoasis™ active noise control device to attenuate typical noises in a ... device attenuated the alarm sounds from patient monitors, ventilators and other bedside devices ...
(Date:7/2/2020)... CITY, Calif. (PRWEB) , ... July 01, 2020 ... ... biotech company, presented its phase 1a findings of Neihulizumab, a biologic for the ... conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company ... Known as MediVet Biologics since its formation in 2016, the company is relaunching ... Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. (Nasdaq: ... advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene ... strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical ...
(Date:7/18/2020)... ... ... After research model surgery and catheter implantation, the long journey of catheter ... of a successful study, while protecting and accessing the catheter or device post-surgery is ... from Envigo in a live webinar on Wednesday, August 5, ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Institute of Technology (MIT) has expanded the company’s exclusive license to include ... into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. ...
Breaking Biology Technology:
Cached News: